Skip to main content

Table 3 Measures of self-efficacy

From: Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine

 

Antenatal survey

Postnatal survey

 

Confident could do

Fairly confident could do

Could not do

Confident could do

Fairly confident could do

Could not do

ART-related self-efficacy

      

1. Keep taking ART if side effects interfere

40% (68/171)

46% (78/171)

15% (25/171)

29% (26/89)

51% (45/89)

20% (18/89)

2. Keep taking ART in front of people unaware of your HIV status

43% (75/175)

46% (81/175)

11% (19/175)

31% (27/88)

59% (52/88)

10% (9/88)

3. Keep taking ART if daily routine disrupted

45% (78/173)

47% (81/173)

8% (14/173)

41% (35/86)

57% (49/86)

2% (2/86)

4. Keep taking ART if not feeling well

43% (77/178)

47% (83/178)

10% (18/178)

24% (20/85)

62% (53/85)

14% (12/85)

5. Keep attending appointments if they interfere with daily activities

36% (54/148)

55% (82/148)

8% (12/148)

45% (32/71)

52% (37/71)

3% (2/71)

Proportion reporting that they could not do ≥1 of 5 ART-related items

20% (28/141)

  

17% (11/66)

  

Help-seeking self-efficacy

      

1. Ask clinician for more information or tell them about concerns or worries

37% (61/167)

56% (94/167)

7% (12/167)

48% (41/86)

49% (42/86)

3% (3/86)

2. Ask someone for support with taking medication if needed

33% (54/165)

47% (78/165)

20% (33/165)

30% (26/86)

43% (37/86)

27% (23/86)